Novel Therapies in Metastatic Melanoma

In this segment, panelists discuss the recent explosion of novel therapies for patients with metastatic melanoma, which includes CTLA-4 and PD-1/PD-L1 checkpoint inhibitors as well as BRAF and MEK targeted therapies.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/metastatic-melanoma